Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma (scientific article published on March 1, 2013)

Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity

Q40699722

A decrease of regulatory T cells correlates with overall survival after sunitinib-based antiangiogenic therapy in metastatic renal cancer patients

Q42858412

L-arginine-dependent reactive nitrogen intermediates as mediators of tumor cell killing by activated macrophages.

Q43411477

Tumor-infiltrating Foxp3-CD4+CD25+ T cells predict poor survival in renal cell carcinoma.

Q43782950

Human anti-inflammatory macrophages induce Foxp3+ GITR+ CD25+ regulatory T cells, which suppress via membrane-bound TGFbeta-1.

Q44823001

Favorable prognosis of renal cell carcinoma with increased expression of chemokines associated with a Th1-type immune response

Q45861280

Role of c-MYC in alternative activation of human macrophages and tumor-associated macrophage biology

Q51544709

Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas

Q51889629

Molecular signature of CD8+ T cell exhaustion during chronic viral infection

Q51970485

CD163

Q56593680

Tumor-associated macrophages mediate immunosuppression in the renal cancer microenvironment by activating the 15-lipoxygenase-2 pathway

Q56898526

The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection

Q57062755

Expression of inducible nitric oxide synthase in colorectal cancer and its association with prognosis

Q73364825

Secretion of interleukin-10 from murine colon carcinoma cells suppresses systemic antitumor immunity and impairs protective immunity induced against the tumors

Q77827429

Frequency of regulatory T cells in renal cell carcinoma patients and investigation of correlation with survival

Q80287221

The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma

Q82672262

IRF5 is required for late-phase TNF secretion by human dendritic cells

Q24303648

Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins

Q24308079

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Q27860475

M-1/M-2 macrophages and the Th1/Th2 paradigm

Q28145893

Coordinated regulation of myeloid cells by tumours

Q28395157

Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression

Q28646286

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

Q29547633

Distinct role of macrophages in different tumor microenvironments

Q29614304

Alternative activation of macrophages: mechanism and functions

Q29614350

Central memory and effector memory T cell subsets: function, generation, and maintenance

Q29615097

Macrophage diversity enhances tumor progression and metastasis

Q29615847

The immune contexture in human tumours: impact on clinical outcome

Q29620667

Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer

Q33280211

Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram

Q33627815

Increased angiogenic sprouting in poor prognosis FL is associated with elevated numbers of CD163+ macrophages within the immediate sprouting microenvironment

Q33931720

CD163: a specific marker of macrophages in paraffin-embedded tissue samples

Q33982414

Role of TGF-beta in immune-evasion of cancer

Q34136492

Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+ T cell dysfunction in melanoma patients

Q34161579

Renal-cell carcinoma

Q34394356

Guideline 'Renal cell carcinoma'

Q34766425

Relevance of Periostin Splice Variants in Renal Cell Carcinoma

Q35167831

Control of autoimmunity by naturally arising regulatory CD4+ T cells

Q35623006

Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation

Q36231523

Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy

Q36414978

Immunotherapy of renal cell carcinoma

Q36468943

Macrophage polarization in tumour progression

Q37158140

Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1.

Q37273173

Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor

Q37480291

Prognostic and predictive biomarkers in renal cell carcinoma

Q37768078

Metastasis: tumor cells becoming MENAcing

Q37808845

The Suppressive Tumor Microenvironment: A Challenge in Cancer Immunotherapy

Q37872288

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

Q37961577

Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy

Q37964608

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

renal cell carcinoma

Q1164529

cell function

Q95674809

P304

page(s)

e23562

P577

publication date

2013-03-01

P1433

published in

OncoImmunology

Q18026500

P1476

title

Tumor-associated macrophages subvert T-cell function and correlate with reduced survival in clear cell renal cell carcinoma

P478

volume

Reverse relations

cites work (P2860)

Q37672108	A CCR4 antagonist reverses the tumor-promoting microenvironment of renal cancer
Q64375454	Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus
Q34350259	Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma
Q33649707	An Immune Atlas of Clear Cell Renal Cell Carcinoma
Q50425077	Anti-metastatic immunotherapy based on mucosal administration of flagellin and immunomodulatory P10.
Q38184386	Biomarkers in renal cancer
Q36806906	Blocking immune checkpoints in prostate, kidney, and urothelial cancer: An overview
Q37559001	Brain metastasis in renal cancer patients: metastatic pattern, tumour-associated macrophages and chemokine/chemoreceptor expression
Q26860058	Cancer microenvironment, inflammation and cancer stem cells: A hypothesis for a paradigm change and new targets in cancer control
Q35799079	Cross-talk between tumors can affect responses to therapy
Q36260281	Dectin-1 Activation by a Natural Product β-Glucan Converts Immunosuppressive Macrophages into an M1-like Phenotype
Q38845203	Differential Expression of Immune Checkpoint Modulators on In Vitro Primed CD4(+) and CD8(+) T Cells
Q33576409	Differential intratumoral distributions of CD8 and CD163 immune cells as prognostic biomarkers in breast cancer
Q35201835	Differential potency of regulatory T cell-mediated immunosuppression in kidney tumors compared to subcutaneous tumors
Q30583272	Dynamic Treg interactions with intratumoral APCs promote local CTL dysfunction
Q33432352	East Coast Fever Caused by Theileria parva Is Characterized by Macrophage Activation Associated with Vasculitis and Respiratory Failure.
Q90050698	Emerging Roles for G-protein Coupled Receptors in Development and Activation of Macrophages
Q38153283	Emerging role of tumor-associated macrophages as therapeutic targets in patients with metastatic renal cell carcinoma.
Q42848419	Enhancing immunotherapy using chemotherapy and radiation to modify the tumor microenvironment
Q35730185	Expression of folate receptors alpha and beta in normal and cancerous gynecologic tissues: correlation of expression of the beta isoform with macrophage markers
Q98513545	HIF-1α and HIF-2α differently regulate tumour development and inflammation of clear cell renal cell carcinoma in mice
Q64101974	Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer
Q35201895	Immune signature of tumor infiltrating immune cells in renal cancer
Q26798402	Immunosuppressive Mechanisms of Malignant Gliomas: Parallels at Non-CNS Sites
Q55039815	In Vivo MR Imaging of Tumor-Associated Macrophages: The Next Frontier in Cancer Imaging.
Q37536932	Infiltrating macrophages increase RCC epithelial mesenchymal transition (EMT) and stem cell-like populations via AKT and mTOR signaling
Q42684353	Inhibition of MYC in macrophages: tumor vs inflammation-related diseases
Q37575163	Innate immune response adaptation in mice subjected to administration of DMBA and physical activity
Q92101821	Integration of intratumoral RASSF10 expression and tumor-associated macrophages into the established clinical indicators better predicts the prognosis of clear cell renal cell carcinoma patients
Q37722095	Interference with Tim-3 protein expression attenuates the invasion of clear cell renal cell carcinoma and aggravates anoikis.
Q89992751	M2 macrophages and regulatory T cells in lethal prostate cancer
Q40421152	Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection
Q34077272	Mechanisms of Acquired Resistance to Tyrosine Kinase Inhibitors in Clear - Cell Renal Cell Carcinoma (ccRCC)
Q48196926	Nestin expression on tumour vessels and tumour-infiltrating macrophages define a poor prognosis subgroup of pt1 clear cell renal cell carcinoma
Q39143622	PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection.
Q33275412	PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment
Q38651976	Papillary renal cell carcinoma-derived chemerin, IL-8, and CXCL16 promote monocyte recruitment and differentiation into foam-cell macrophages.
Q30268502	Potential immunotherapy targets in recurrent cervical cancer
Q35880843	Prognostic Implication of M2 Macrophages Are Determined by the Proportional Balance of Tumor Associated Macrophages and Tumor Infiltrating Lymphocytes in Microsatellite-Unstable Gastric Carcinoma
Q54995947	Receptors That Inhibit Macrophage Activation: Mechanisms and Signals of Regulation and Tolerance.
Q26742012	Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting
Q38763283	Relationship between tumor-associated macrophage subsets and CD47 expression in squamous cell carcinoma of the head and neck in the tumor microenvironment
Q41789122	Resistance to Antiangiogenic Therapy Is Associated with an Immunosuppressive Tumor Microenvironment in Metastatic Renal Cell Carcinoma
Q38904869	Role of tumor-associated macrophages in human malignancies: friend or foe?
Q91429973	Specific immune cell and lymphatic vessel signatures identified by image analysis in renal cancer
Q36347369	T-cell exhaustion in the tumor microenvironment
Q37729313	TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
Q38835677	TNF Counterbalances the Emergence of M2 Tumor Macrophages
Q39076005	The Essential Role of Type I Interferons in Differentiation and Activation of Tumor-Associated Neutrophils
Q90290702	The Role of the Lymphocyte Functional Crosstalk and Regulation in the Context of Checkpoint Inhibitor Treatment-Review
Q60959822	The Sweet Surrender: How Myeloid Cell Metabolic Plasticity Shapes the Tumor Microenvironment
Q26783291	The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy
Q46882215	The predominance of M2-polarized macrophages in the stroma of low-hypoxic bladder tumors is associated with BCG immunotherapy failure.
Q90643605	Transcriptional profiling of tumor associated macrophages in human renal cell carcinoma reveals significant heterogeneity and opportunity for immunomodulation
Q43104064	Trial Watch: Radioimmunotherapy for oncological indications
Q92912501	Tumor-associated macrophage expression of interferon regulatory Factor-8 (IRF8) is a predictor of progression and patient survival in renal cell carcinoma

P356	DOI	10.4161/ONCI.23562
P8608	Fatcat ID	release_m77qrwmm75ftrbkqidjzx7xikm
P953	full work available online at	http://www.tandfonline.com/doi/pdf/10.4161/onci.23562
		https://europepmc.org/articles/PMC3655740
		https://europepmc.org/articles/PMC3655740?pdf=render
		https://www.tandfonline.com/doi/pdf/10.4161/onci.23562?needAccess=true
P932	PMC publication ID	3655740
P698	PubMed publication ID	23687622
P5875	ResearchGate publication ID	236921948